ST
Strand Therapeutics Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$108.1Msold at filing
Total offering$120.1M$12M still open
Investors in the raise10count reported to the SEC
FiledMar 17, 2026first sale May 23, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jeb KeiperDirector
Ala AlenaziDirector
Pegah EbrahimiDirector
Tasuku KitadaExecutive Officer, Director, Promoter
Samta KunduExecutive Officer
Jory BellDirector
Jacob BecraftExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.